{
    "eid": "2-s2.0-85151495066",
    "title": "The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs",
    "cover-date": "2023-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "controlling transmission",
        "COVAX",
        "COVID-19 vaccine lessons",
        "disease X and pathogen X",
        "epidemic and pandemic prevention",
        "low- and middle-income country (LMIC) vaccine innovation and manufacture",
        "modular vaccine production",
        "mucosal immunity",
        "pan-coronavirus vaccines",
        "platform technologies (esp. inactivated viruses; recombinant proteins; viral vectors; mRNA)",
        "public investments and subsidies",
        "R&D blueprints",
        "regulatory challenges",
        "technology global commons and global public goods",
        "vaccine access",
        "vaccine business model and value proposition",
        "vaccine intellectual property (IP) and know-how transfer",
        "vaccine prototypes",
        "variants and booster strategies"
    ],
    "authors": [
        "Andrew Farlow",
        "Els Torreele",
        "Glenda Gray",
        "Kiat Ruxrungtham",
        "Helen Rees",
        "Sai Prasad",
        "Carolina Gomez",
        "Amadou Sall",
        "Jorge Magalh\u00e3es",
        "Piero Olliaro",
        "Petro Terblanche"
    ],
    "citedby-count": 2,
    "ref-count": 104,
    "ref-list": [
        "Global impact of the first year of COVID-19 vaccination: A mathematical modelling study",
        "US COVID-19 vaccination efforts may have prevented more than 1 million deaths, 10 million hospitalizations",
        "Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data",
        "The next pandemic: Prepare for \u201cDisease X",
        "Disease X: Accelerating the development of medical countermeasures for the next pandemic",
        "Why are RNA virus mutation rates so damn high?",
        "Data and product needs for influenza immunization programs in low-and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines",
        "Seasonal influenza vaccine dose distribution in 195 countries (2004\u20132013): Little progress in estimated global vaccination coverage",
        "Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity",
        "Operation Warp Speed: Implications for global vaccine security",
        "Developing safe and effective Covid vaccines\u2014Operation Warp Speed\u2019s strategy and approach",
        "Risky business: COVAX and the financialization of global vaccine equity",
        "Pandemic vaccine equity plan may soon start winding down",
        "AstraZeneca\u2019s COVID-19 (mis) adventure and the future of vaccine equity",
        "Geographic and genomic distribution of SARS-CoV-2 mutations",
        "SARS-CoV-2 evolution and vaccines: Cause for concern?",
        "COVID \u2018Variant Soup\u2019 Is Making Winter Surges Hard to Predict",
        "How nasal-spray vaccines could change the pandemic",
        "Sixty seconds on \u2026 nasal vaccines",
        "Operation nasal vaccine\u2014Lightning speed to counter COVID-19",
        "What next for covid-19 vaccines?",
        "Why Efforts to Make Better, More Universal Coronavirus Vaccines Are Struggling",
        "China and India Approve Nasal COVID Vaccines",
        "Endpoints in vaccine trials",
        "A framework for assessing immunological correlates of protection in vaccine trials",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "SARS-CoV-2 S2\u2013targeted vaccination elicits broadly neutralizing antibodies",
        "The BMJ Interview: WHO chief scientist optimistic for a pan-coronavirus vaccine in two years",
        "On the origin and evolution of SARS-CoV-2",
        "A universal coronavirus vaccine",
        "Conserved genomic terminals of SARS-CoV-2 as coevolving functional elements and potential therapeutic targets",
        "SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes",
        "Looking to the future: Is a universal coronavirus vaccine feasible?",
        "Promoting versatile vaccine development for emerging pandemics",
        "Current developments and challenges of mRNA vaccines",
        "Stopping epidemics when and where they occur",
        "Heterologous prime\u2013boost strategies for COVID-19 vaccines",
        "Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination",
        "The future of vaccine manufacturing in Africa",
        "How COVID Spurred Africa to Plot a Vaccines Revolution",
        "Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: Considerations, requirements, and opportunities",
        "The fight to manufacture COVID vaccines in lower-income countries",
        "COVID-19: Rich countries\u2019 booster plans will impede global vaccination, experts say",
        "The Challenge of Knowledge Management in Global Health in Pandemic Time",
        "Preparing for the next pandemic requires public health focused industrial policy",
        "Vaccines, therapeutics, and diagnostics for covid-19: Redesigning systems to improve pandemic response",
        "Reboot Biomedical R&D in the Global Public Interest",
        "The world must act now to be prepared for future health emergencies",
        "Global challenges in preparedness and response to epidemic infectious diseases",
        "Emergence and dissemination of monkeypox, an intimidating global public health problem",
        "Monkeypox: The Consequences of Neglecting a Disease, Anywhere",
        "Breakthrough treatments for Ebola virus disease, but no access-what went wrong, and how can we do better?",
        "Tecovirimat for monkeypox in Central African Republic under expanded access",
        "The coronavirus is mutating\u2014Does it matter?"
    ],
    "affiliation": [
        {
            "affiliation-city": "Oxford",
            "@id": "60175816",
            "affilname": "Oxford Social Sciences Division",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60175816",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Dakar",
            "@id": "60071556",
            "affilname": "Institut Pasteur de Dakar",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071556",
            "affiliation-country": "Senegal"
        },
        {
            "affiliation-city": "Bogota",
            "@id": "60055696",
            "affilname": "Universidad Nacional de Colombia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60055696",
            "affiliation-country": "Colombia"
        },
        {
            "affiliation-city": "Tygerberg",
            "@id": "60028973",
            "affilname": "South African Medical Research Council",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028973",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Oxford",
            "@id": "60026851",
            "affilname": "University of Oxford",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026851",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Rio de Janeiro",
            "@id": "60026004",
            "affilname": "Fundacao Oswaldo Cruz",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026004",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "London",
            "@id": "60022148",
            "affilname": "University College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Johannesburg",
            "@id": "60016218",
            "affilname": "University of the Witwatersrand, Johannesburg",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016218",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Oxford",
            "@id": "60008936",
            "affilname": "Nuffield Department of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008936",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Cape Town",
            "@id": "125591609",
            "affilname": "Afrigen Biologics (Pty) Limited",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125591609",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Hyderabad",
            "@id": "102011093",
            "affilname": "Bharat Biotech International Limited",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/102011093",
            "affiliation-country": "India"
        }
    ],
    "funding": []
}